Evidence map›Paper›PMID 35482592›Full record

ArticleACS chemical neuroscience2022

Effectiveness and Relationship between Biased and Unbiased Measures of Dopamine Release and Clearance.

Anna C Everett, Ben E Graul, Joakim W Ronström, J Kayden Robinson, Daniel B Watts, Rodrigo A España, Cody A Siciliano, Jordan T Yorgason

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Dopamine Pharmacodynamics: New Insights.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna C EverettDepartment of Cellular Biology and Physiology, Brigham Young University, Provo, Utah 84602, United States.
Ben E GraulDepartment of Cellular Biology and Physiology, Brigham Young University, Provo, Utah 84602, United States.
Joakim W RonströmDepartment of Cellular Biology and Physiology, Brigham Young University, Provo, Utah 84602, United States.
J Kayden RobinsonDepartment of Cellular Biology and Physiology, Brigham Young University, Provo, Utah 84602, United States.
Daniel B WattsDepartment of Cellular Biology and Physiology, Brigham Young University, Provo, Utah 84602, United States.
Rodrigo A EspañaDepartment of Neurobiology & Anatomy, Drexel University, Philadelphia, Pennsylvania 28619, United States.
Cody A SicilianoCenter for Addiction Research, Vanderbilt University, Nashville, Tennessee 37203, United States.
Jordan T YorgasonDepartment of Cellular Biology and Physiology, Brigham Young University, Provo, Utah 84602, United States.ORCID 0000-0002-5687-0676

Funding

Involvement of hypocretin-orexin in the regulation of dopamine signaling and reinforcement processes in femalesR01DA031900 · NIDA · DREXEL UNIVERSITY · PI ESPAÑA, RODRIGO A. · 2013 to 2022
$3.6M
Mesocortical neuromodulation in punishment-resistant alcohol drinkingR01AA030115 · NIAAA · VANDERBILT UNIVERSITY · PI Cody Siciliano · 2022 to 2026
$2.1M
Defining the role of cortical circuit dynamics in learning and addictionR00DA045103 · NIDA · VANDERBILT UNIVERSITY · PI SICILIANO, CODY · 2020 to 2022
$764k
Assessing if distinct susceptibility to neutralization of cell-free and cell-to-cell spread impacts antibody conferred protection from SHIV infectionK01OD031900 · OD · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI PARSONS, MATTHEW SIDNEY · 2021 to 2023
$639k
Cocaine Enhances Spontaneous Dopamine Release by Increasing Cholinergic ActivityF32DA040409 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI YORGASON, JORDAN THOMAS · 2015 to 2015
$52k
NIAAA NIH HHS R01 AA030115NIDA NIH HHS F32 DA040409NIDA NIH HHS R00 DA045103NIDA NIH HHS R01 DA031900NIH HHS K01 OD031900
6 · The paper itself

Abstract

Fast-scan cyclic voltammetry (FSCV) is an effective tool for measuring dopamine release and clearance throughout the brain, especially the striatum where dopamine terminals are abundant and signals are heavily regulated by release machinery and the dopamine transporter (DAT). Peak height measurement is perhaps the most common method for measuring dopamine release, but it is influenced by changes in clearance. Michaelis-Menten-based modeling has been a standard in measuring dopamine clearance, but it is problematic in that it requires experimenter fitted modeling subject to experimenter bias. This study presents the use of the first derivative (velocity) of evoked dopamine signals as an alternative approach for measuring and distinguishing dopamine release from clearance. Maximal upward velocity predicts reductions in dopamine peak height due to D

Indexed as

CocaineDopamineAnimalsCorpus StriatumDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsMiceRatsRats, Sprague-DawleyCocaineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake Inhibitorsdopaminedopamine transporterfast-scan cyclic voltammetrykineticsMichaelis−Mentenstriatum

Identifiers

PMID35482592
PMCPMC10763521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.